SCHEMBL29344299

SCHEMBL29344299

c1ccc2c(c1)c1ccccc1c1nc(-c3cnc4c5ccccc5c5ccccc5c4n3)cnc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.37
GPR3 P46089 1/20 0.37
MAPT P10636 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36
BLM P54132 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HPRT1 P00492 1/20 0.35
CYP1A2 P05177 2/20 0.34
HIF1A Q16665 2/20 0.34
DHFR P00374 1/20 0.34
CYP3A4 P08684 1/20 0.34
NPC1 O15118 2/20 0.33
CCR1 P32246 1/20 0.33
CCR5 P51681 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1714314 0.87 RAB9A (0.44) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL16543290 0.87 NPC1 (0.42) ALDH1A1L3MBTL1KDM4EMAPTMEN1
SCHEMBL29925923 0.87 RAB9A (0.44) ALDH1A1L3MBTL1MAPTMEN1KMT2A
SCHEMBL16543242 0.87 NPC1 (0.37) ALDH1A1L3MBTL1MAPTNPC1CYP11B1
SCHEMBL16543248 0.84 NPC1 (0.44) KDM4ENPC1CYP11B1RAB9ASMN1; SMN2
SCHEMBL16534768 0.82 NPC1 (0.42) KDM4ENPC1CYP11B1RAB9ASMN1; SMN2
SCHEMBL12722972 0.82 NOS1 (0.52) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL16543240 0.82 NPC1 (0.42) KDM4ENPC1CYP11B1RAB9ASMN1; SMN2
SCHEMBL16543241 0.82 NPC1 (0.42) KDM4ENPC1CYP11B1RAB9ASMN1; SMN2
SCHEMBL16535106 0.81 RAB9A (0.57) ALDH1A1L3MBTL1KDM4EMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240244859-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2024-07-18 US disclosed
US-20240244859-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240244859-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE APBA1, OLA1, AOC2 ALDH1A1 76/4885L3MBTL1 579/4885KDM4E 3719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.